Team:Paris/Addressing overview2 strategy
From 2009.igem.org
Cha.olivier (Talk | contribs) (→Adressing the message in the membrane : Our strategy) |
Christophe.R (Talk | contribs) |
||
(5 intermediate revisions not shown) | |||
Line 4: | Line 4: | ||
- | == | + | <span/ id="1"> |
+ | ==Addressing the message in the membrane : Our strategy== | ||
<html> | <html> | ||
<style type="text/css"> | <style type="text/css"> | ||
Line 69: | Line 70: | ||
Our strategy is to use clyA to export a protein to the outer-membrane of the cell. The protein fused to clyA will be incorporated into the vesicle during the vesiculation process and it's also express on the surface. ClyA contain the signal peptide required for the exportation process from the cytoplasm to the periplasm. The overall idea is to fused the protein of interest to clyA. | Our strategy is to use clyA to export a protein to the outer-membrane of the cell. The protein fused to clyA will be incorporated into the vesicle during the vesiculation process and it's also express on the surface. ClyA contain the signal peptide required for the exportation process from the cytoplasm to the periplasm. The overall idea is to fused the protein of interest to clyA. | ||
- | So in a first time in order to see if our ClyA are localize in OMVs, we fused it we a RFP. For that we add a poly glycine linker to ClyA biobrick to improve ClyA-RFP fusion. Moreover if we put RFP before ClyA, it seem that there is more fluorescence than ClyA before RFP under [[ | + | So in a first time in order to see if our ClyA are localize in OMVs, we fused it we a RFP. For that we add a poly glycine linker to ClyA biobrick to improve ClyA-RFP fusion. Moreover if we put RFP before ClyA, it seem that there is more fluorescence than ClyA before RFP under <sup>[[Team:Paris/Addressing_overview2#References|[1]]]</sup>. You can see the contruction [https://2009.igem.org/Team:Paris/Addressing_overview_Construction#Overview here] |
+ | |||
+ | Then if this test work, we could replace the RFP by the protein of interest for signal transduction, moreover this system couple to fec system can transduct a signal from outer membran to the cytoplasm. | ||
- | |||
{{Template:Paris2009_guided|Addressing_overview4#bottom|Production_overview#top}} | {{Template:Paris2009_guided|Addressing_overview4#bottom|Production_overview#top}} | ||
+ | <html> | ||
+ | </div> | ||
+ | <div id="paris_content_boxtop"> | ||
+ | </div> | ||
+ | <div id="paris_content"> | ||
+ | </html> | ||
+ | ====References==== | ||
+ | <ol class="references"> | ||
+ | <li>[[Team:Paris/Addressing_overview2#1| ^]]J.Y. Kim, A.M. Doody, D. J. Chen, G.H. Cremona, M.L. Shuler, D.Putnam,and M.P. DeLisa.Engineered. Bacterial Outer Membrane Vesicles with Enhanced Functionality, 2008, J. Mol. Biol. 380, 51–66. [http://www.ncbi.nlm.nih.gov/pubmed/18511069 18511069]</li> | ||
+ | </ol> |
Latest revision as of 02:59, 22 October 2009
iGEM > Paris > ClyA > Our strategy
Addressing the message in the membrane : Our strategy
Our strategy is to use clyA to export a protein to the outer-membrane of the cell. The protein fused to clyA will be incorporated into the vesicle during the vesiculation process and it's also express on the surface. ClyA contain the signal peptide required for the exportation process from the cytoplasm to the periplasm. The overall idea is to fused the protein of interest to clyA.
So in a first time in order to see if our ClyA are localize in OMVs, we fused it we a RFP. For that we add a poly glycine linker to ClyA biobrick to improve ClyA-RFP fusion. Moreover if we put RFP before ClyA, it seem that there is more fluorescence than ClyA before RFP under [1]. You can see the contruction here
Then if this test work, we could replace the RFP by the protein of interest for signal transduction, moreover this system couple to fec system can transduct a signal from outer membran to the cytoplasm.
References
- ^J.Y. Kim, A.M. Doody, D. J. Chen, G.H. Cremona, M.L. Shuler, D.Putnam,and M.P. DeLisa.Engineered. Bacterial Outer Membrane Vesicles with Enhanced Functionality, 2008, J. Mol. Biol. 380, 51–66. [http://www.ncbi.nlm.nih.gov/pubmed/18511069 18511069]